We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers to Focus on 10 Data Points in U.S. Quality Metrics Thrust
Drugmakers to Focus on 10 Data Points in U.S. Quality Metrics Thrust
The U.S. Food and Drug Administration has identified 10 quality data points that finished dosage form and active pharmaceutical ingredient makers will need to collect to calculate four quality metrics for each product they produce.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor